Brief: Amylyx Pharmaceuticals Announces $350 Million Proposed Public Offering Of Common Stock
18/08/2026 21:05
BRIEF-Amylyx Pharmaceuticals Announces $350 Million Proposed Public Offering Of Common Stock Aug 18 (Reuters) - Amylyx Pharmaceuticals, Inc. AMLX.O:
AMYLYX PHARMACEUTICALS ANNOUNCES $350.0 MILLION PROPOSED PUBLIC OFFERING OF COMMON STOCK
AMYLYX PHARMACEUTICALS, - PROCEEDS TO FUND AVEXITIDE PRE-COMMERCIAL ACTIVITIES, RESEARCH AND DEVELOPMENT, AND GENERAL CORPORATE PURPOSES
Source text: ID:nBwbJf7spa
Further company coverage: AMLX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amylyx Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-LSI Industries, SiTime, Andersen Group
U.S. STOCKS ON THE MOVE-Apple, Hims & Hers Health, Sysco
U.S. STOCKS ON THE MOVE-Nordson, Nebius, Deere
Amylyx dips after increased $500 mln stock sale to fund blood sugar drug
Brief: Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock